Journal of Clinical Endocrinology & Metabolism, Vol 60, 1204-1209, Copyright © 1985 by Endocrine Society

ARTICLES

Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin

GP Ceda, AR Hoffman, GD Silverberg, DM Wilson and RG Rosenfeld

GH secretion is stimulated by hypothalamic GH-releasing factor (GHRH) and inhibited by somatostatin. Since GH induces the production of insulin-like growth factors (IGF) in liver and other tissues, it is of interest to learn whether IGF alters GH release through long loop feedback inhibition. Pituitary adenomas which had been removed from six acromegalic patients were processed for dispersed cell cultures and/or cell membrane preparations. Binding studies using 125I-labeled IGF-I, IGF-II, and insulin revealed specific hormone binding for each ligand to cell membranes derived from four somatotropinomas. A partially purified somatomedin preparation inhibited basal and/or GHRH-stimulated GH release from cultured pituitary cells derived from three of four adenomas; there was no effect of somatomedin in one tumor. In a single tumor, insulin also partially inhibited GHRH-stimulated GH release. Additionally, in one nonadenomatous pituitary removed from a patient with diabetes mellitus, insulin and somatomedin inhibited GHRH- stimulated GH release, and insulin inhibited basal GH secretion. These results indicate that specific cell membrane receptors for somatomedin peptides and insulin may be found on cell membranes from GH-secreting tumors, and that somatomedins and insulin can inhibit GH release in cultured human somatotropinoma cells. Thus, these data suggest that somatomedins may exert feedback inhibition of GH secretion in some patients with acromegaly.

This article has been cited by other articles:

				P. Kok, M. M. Buijs, S. W. Kok, I. H. A. P. van Ierssel, M. Frolich, F. Roelfsema, P. J. Voshol, A. E. Meinders, and H. Pijl Acipimox enhances spontaneous growth hormone secretion in obese women Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R693 - R698. [Abstract] [Full Text] [PDF]

				C. A. Jaffe, W. Pan, M. B. Brown, R. DeMott-Friberg, and A. L. Barkan Regulation of GH Secretion in Acromegaly: Reproducibility of Daily GH Profiles and Attenuated Negative Feedback by IGF-I J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4364 - 4370. [Abstract] [Full Text] [PDF]

				P. Villa, L. Soranna, A. Mancini, L. De Marinis, D. Valle, S. Mancuso, and A. Lanzone Effect of feeding on growth hormone response to growth hormone-releasing hormone in polycystic ovarian syndrome: relation with body weight and hyperinsulinism Hum. Reprod., March 1, 2001; 16(3): 430 - 434. [Abstract] [Full Text] [PDF]

				R. Lanzi, M. Losa, G. Mignogna, A. Caumo, and A. E. Pontiroli The Control on Growth Hormone Release by Free Fatty Acids Is Maintained in Acromegaly J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1234 - 1238. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				A. Rahim, P. A. O’Neill, and S. M. Shalet Growth Hormone Status during Long-Term Hexarelin Therapy J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1644 - 1649. [Abstract] [Full Text]

				R. Lanzi, M. F. Manzoni, A. C. Andreotti, M. E. Malighetti, E. Bianchi, L. P. Sereni, A. Caumo, L. Luzi, and A. E. Pontiroli Evidence for an Inhibitory Effect of Physiological Levels of Insulin on the Growth Hormone (GH) Response to GH-Releasing Hormone in Healthy Subjects J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2239 - 2243. [Abstract] [Full Text] [PDF]